{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:19:44Z","timestamp":1777951184606,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","award":["14-2326"],"award-info":[{"award-number":["14-2326"]}],"id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to investigate migraine diagnoses in a hospital setting, use of prescription migraine medicine and levels of serotonin in patients with atrial septal defect. Using Danish national registries to identify all patients born before 1994 diagnosed with atrial septal defect between 1959 and 2013, thus including 2277 patients and a gender and age matched comparison cohort of 22756. Plasma serotonin was measured in 136 patients with a small, unclosed, atrial septal defects and 18 controls. Patients with atrial septal defect had an increased risk of receiving a migraine diagnosis (HR 3.4 (95% CI: 2.6\u20134.6)) and receiving migraine medicine (HR 1.8 (95% CI: 1.2\u20132.5)). Ten years after closure, 93% of those using migraine medicine pre-closure, were still receiving this. The risk of having very high plasma serotonin levels was increased in patients with atrial septal defect compared with the control group, but there was no difference in the median values between the two groups. Migraine and use of migraine medicine were increased in atrial septal defect patients. The use of medicine was not diminished by closure of the defect. Plasma serotonin was severely elevated in 18% of the patients with atrial septal defect.<\/jats:p>","DOI":"10.1038\/s41598-019-43895-z","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T10:03:46Z","timestamp":1557914626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Burden of Migraine in Adults with Atrial Septal Defect: A Nationwide Cohort Study"],"prefix":"10.1038","volume":"9","author":[{"given":"Camilla","family":"Nyboe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Hyldahl","family":"Nymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sif","family":"Ovesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Elisabeth Hjortdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"43895_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.amjcard.2007.10.034","volume":"101","author":"J Rodes-Cabau","year":"2008","unstructured":"Rodes-Cabau, J. et al. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale. Am J Cardiol 101, 688\u2013692, https:\/\/doi.org\/10.1016\/j.amjcard.2007.10.034 (2008).","journal-title":"Am J Cardiol"},{"key":"43895_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1526-4610.2006.00433.x","volume":"46","author":"TJ Schwedt","year":"2006","unstructured":"Schwedt, T. J. & Dodick, D. W. Patent foramen ovale and migraine\u2013bringing closure to the subject. Headache 46, 663\u2013671, https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00433.x (2006).","journal-title":"Headache"},{"key":"43895_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1468-2982.2005.01024.x","volume":"26","author":"EA Wammes-van der Heijden","year":"2006","unstructured":"Wammes-van der Heijden, E. A., Tijssen, C. C. & Egberts, A. C. Right-to-left shunt and migraine: the strength of the relationship. Cephalalgia: an international journal of headache 26, 208\u2013213, https:\/\/doi.org\/10.1111\/j.1468-2982.2005.01024.x (2006).","journal-title":"Cephalalgia: an international journal of headache"},{"key":"43895_CR4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1526-4610.2012.02162.x","volume":"52","author":"P Borgdorff","year":"2012","unstructured":"Borgdorff, P. & Tangelder, G. J. Migraine: possible role of shear-induced platelet aggregation with serotonin release. Headache 52, 1298\u20131318, https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02162.x (2012).","journal-title":"Headache"},{"key":"43895_CR5","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.52.8.1622","volume":"52","author":"GP Anzola","year":"1999","unstructured":"Anzola, G. P., Magoni, M., Guindani, M., Rozzini, L. & Dalla Volta, G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 52, 1622\u20131625 (1999).","journal-title":"Neurology"},{"key":"43895_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000015875","volume":"8","author":"M Del Sette","year":"1998","unstructured":"Del Sette, M. et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovascular diseases (Basel, Switzerland) 8, 327\u2013330, https:\/\/doi.org\/10.1159\/000015875 (1998).","journal-title":"Cerebrovascular diseases (Basel, Switzerland)"},{"key":"43895_CR7","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1212\/wnl.0000000000006572","volume":"91","author":"RJ Sommer","year":"2018","unstructured":"Sommer, R. J., Nazif, T., Privitera, L. & Robbins, B. T. Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale. Neurology 91, 1002\u20131009, https:\/\/doi.org\/10.1212\/wnl.0000000000006572 (2018).","journal-title":"Neurology"},{"key":"43895_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1212\/wnl.0000000000006573","volume":"91","author":"AM Reisman","year":"2018","unstructured":"Reisman, A. M. et al. Ticagrelor for Refractory Migraine\/Patent Foramen Ovale (TRACTOR): An open-label pilot study. Neurology 91, 1010\u20131017, https:\/\/doi.org\/10.1212\/wnl.0000000000006573 (2018).","journal-title":"Neurology"},{"key":"43895_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/02699050210154240","volume":"16","author":"TW Teasdale","year":"2002","unstructured":"Teasdale, T. W. & Engberg, A. W. Disability pensions in relation to stroke: a population study. Brain injury 16, 997\u20131009, https:\/\/doi.org\/10.1080\/02699050210154240 (2002).","journal-title":"Brain injury"},{"key":"43895_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-63","volume":"14","author":"Y Kato","year":"2013","unstructured":"Kato, Y., Hayashi, T., Kobayashi, T. & Tanahashi, N. Migraine prevalence in patients with atrial septal defect. The journal of headache and pain 14, 63, https:\/\/doi.org\/10.1186\/1129-2377-14-63 (2013).","journal-title":"The journal of headache and pain"},{"key":"43895_CR11","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ccd.22226","volume":"74","author":"JG Luermans","year":"2009","unstructured":"Luermans, J. G. et al. Is a predominant left-to-right shunt associated with migraine? A prospective atrial septal defect closure study. Catheter Cardiovasc Interv 74, 1078\u20131084, https:\/\/doi.org\/10.1002\/ccd.22226 (2009).","journal-title":"Catheter Cardiovasc Interv"},{"key":"43895_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1179\/acb.2008.048","volume":"63","author":"A Voet","year":"2008","unstructured":"Voet, A. et al. New-onset and persistent migraine early after percutaneous atrial septal defect closure disappear at follow-up. Acta clinica Belgica 63, 262\u2013268, https:\/\/doi.org\/10.1179\/acb.2008.048 (2008).","journal-title":"Acta clinica Belgica"},{"key":"43895_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1212\/01.wnl.0000179800.73706.20","volume":"65","author":"M Schwerzmann","year":"2005","unstructured":"Schwerzmann, M. et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65, 1415\u20131418, https:\/\/doi.org\/10.1212\/01.wnl.0000179800.73706.20 (2005).","journal-title":"Neurology"},{"key":"43895_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jacc.2004.09.075","volume":"45","author":"B Azarbal","year":"2005","unstructured":"Azarbal, B. et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 45, 489\u2013492, https:\/\/doi.org\/10.1016\/j.jacc.2004.09.075 (2005).","journal-title":"J Am Coll Cardiol"},{"key":"43895_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fneur.2017.00068","volume":"8","author":"CS Leger","year":"2017","unstructured":"Leger, C. S. & DeSouza, J. F. Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review. Frontiers in neurology 8, 68, https:\/\/doi.org\/10.3389\/fneur.2017.00068 (2017).","journal-title":"Frontiers in neurology"},{"key":"43895_CR16","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","volume":"70","author":"JM Tobis","year":"2017","unstructured":"Tobis, J. M. et al. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial. J Am Coll Cardiol 70, 2766\u20132774, https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1105 (2017).","journal-title":"J Am Coll Cardiol"},{"key":"43895_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt, M., Pedersen, L. & Sorensen, H. T. The Danish Civil Registration System as a tool in epidemiology. European journal of epidemiology 29, 541\u2013549, https:\/\/doi.org\/10.1007\/s10654-014-9930-3 (2014).","journal-title":"European journal of epidemiology"},{"issue":"12","key":"43895_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/eurheartj\/ehx687","volume":"39","author":"Camilla Nyboe","year":"2017","unstructured":"Nyboe, C., Karunanithi, Z., Nielsen-Kudsk, J. E. & Hjortdal, V. E. Long-term mortality in patients with atrial septal defect: a nationwide cohort-study. Eur Heart J, https:\/\/doi.org\/10.1093\/eurheartj\/ehx687 (2017).","journal-title":"European Heart Journal"},{"key":"43895_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.03.063","author":"C Nyboe","year":"2014","unstructured":"Nyboe, C., Olsen, M. S., Nielsen-Kudsk, J. E., Johnsen, S. P. & Hjortdal, V. E. Risk of Pneumonia in Adults With Closed Versus Unclosed Atrial Septal Defect (from a Nationwide Cohort Study). Am J Cardiol, https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.063 (2014).","journal-title":"Am J Cardiol"},{"key":"43895_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/heartjnl-2014-306552","volume":"101","author":"C Nyboe","year":"2015","unstructured":"Nyboe, C., Olsen, M. S., Nielsen-Kudsk, J. E. & Hjortdal, V. E. Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure. Heart 101, 706\u2013711, https:\/\/doi.org\/10.1136\/heartjnl-2014-306552 (2015).","journal-title":"Heart"},{"key":"43895_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes, H. W., Sorensen, H. T. & Hallas, J. The Danish National Prescription Registry. Scandinavian journal of public health 39, 38\u201341, https:\/\/doi.org\/10.1177\/1403494810394717 (2011).","journal-title":"Scandinavian journal of public health"},{"key":"43895_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10194-012-0458-1","volume":"13","author":"Y Kato","year":"2012","unstructured":"Kato, Y., Furuya, D., Ishido, H., Kobayashi, T. & Tanahashi, N. New-onset migraine with aura after transcatheter closure of atrial septal defect. The journal of headache and pain 13, 493\u2013495, https:\/\/doi.org\/10.1007\/s10194-012-0458-1 (2012).","journal-title":"The journal of headache and pain"},{"key":"43895_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1468-2982.2007.01476.x","volume":"27","author":"E Hamel","year":"2007","unstructured":"Hamel, E. Serotonin and migraine: biology and clinical implications. Cephalalgia: an international journal of headache 27, 1293\u20131300, https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01476.x (2007).","journal-title":"Cephalalgia: an international journal of headache"},{"key":"43895_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10194-008-0058-2","volume":"9","author":"A Panconesi","year":"2008","unstructured":"Panconesi, A. Serotonin and migraine: a reconsideration of the central theory. The journal of headache and pain 9, 267\u2013276, https:\/\/doi.org\/10.1007\/s10194-008-0058-2 (2008).","journal-title":"The journal of headache and pain"},{"key":"43895_CR25","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1373\/clinchem.2011.163824","volume":"57","author":"T Brand","year":"2011","unstructured":"Brand, T. & Anderson, G. M. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clinical chemistry 57, 1376\u20131386, https:\/\/doi.org\/10.1373\/clinchem.2011.163824 (2011).","journal-title":"Clinical chemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43895-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:37:21Z","timestamp":1671269841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43895-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43895"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43895-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7410"}}